Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-251874

Chief Legal Officer sold 2,678 shares at $12.00 ($32,136)

  • Chief Legal Officer acquired 1,084 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bizily Scott · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-24 Exercise or conversion : show line 1 in the form 10b5-1 +1,084 $6.49 $7,035 6,272 D
2025-10-24 Sale : show line 2 in the form 10b5-1 −2,678 $12.00 $32,136 3,594 D
Open-market sales · 2,678 sh · avg $12.00 · $32,136

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-24 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −1,084 9,295 D
Loading xslF345X05/ownership.xml…